These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 26634638)

  • 1. Fighting Cancer with Transition Metal Complexes: From Naked DNA to Protein and Chromatin Targeting Strategies.
    Palermo G; Magistrato A; Riedel T; von Erlach T; Davey CA; Dyson PJ; Rothlisberger U
    ChemMedChem; 2016 Jun; 11(12):1199-210. PubMed ID: 26634638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent development of transition metal complexes with in vivo antitumor activity.
    Liang JX; Zhong HJ; Yang G; Vellaisamy K; Ma DL; Leung CH
    J Inorg Biochem; 2017 Dec; 177():276-286. PubMed ID: 28641893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Multi-Targeted Platinum and Ruthenium Drugs-A New Paradigm in Cancer Drug Treatment Regimens?
    Kenny RG; Marmion CJ
    Chem Rev; 2019 Jan; 119(2):1058-1137. PubMed ID: 30640441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metal complex interactions with DNA.
    Pages BJ; Ang DL; Wright EP; Aldrich-Wright JR
    Dalton Trans; 2015 Feb; 44(8):3505-26. PubMed ID: 25427534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-cancer property and DNA binding interaction of first row transition metal complexes: A decade update.
    Dasmahapatra U; Maiti B; Alam MM; Chanda K
    Eur J Med Chem; 2024 Sep; 275():116603. PubMed ID: 38936150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unveiling the Potential of Transition Metal Complexes for Medicine: Translational in Situ Activation of Metal-Based Drugs from Bench to in Vivo Applications.
    Silva MJSA; Gois PMP; Gasser G
    Chembiochem; 2021 May; 22(10):1740-1742. PubMed ID: 33507625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal based biologically active compounds: Design, synthesis, DNA binding and antidiabetic activity of 6-methyl-3-formyl chromone derived hydrazones and their metal (II) complexes.
    Philip JE; Shahid M; Prathapachandra Kurup MR; Velayudhan MP
    J Photochem Photobiol B; 2017 Oct; 175():178-191. PubMed ID: 28892754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ruthenium Complexes: An Emerging Ground to the Development of Metallopharmaceuticals for Cancer Therapy.
    Abid M; Shamsi F; Azam A
    Mini Rev Med Chem; 2016; 16(10):772-86. PubMed ID: 26423699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances in multinuclear complexes as potential anticancer and DNA binding agents.
    Wang K; Gao E
    Anticancer Agents Med Chem; 2014 Jan; 14(1):147-69. PubMed ID: 23869783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Luminescent and Photofunctional Transition Metal Complexes: From Molecular Design to Diagnostic and Therapeutic Applications.
    Lee LC; Lo KK
    J Am Chem Soc; 2022 Aug; 144(32):14420-14440. PubMed ID: 35925792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent and noncovalent interactions of coordination compounds with DNA: An overview.
    Andrezálová L; Országhová Z
    J Inorg Biochem; 2021 Dec; 225():111624. PubMed ID: 34653826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azaindoles: Suitable ligands of cytotoxic transition metal complexes.
    Štarha P; Trávníček Z
    J Inorg Biochem; 2019 Aug; 197():110695. PubMed ID: 31054487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porphyrin complexes of the period 6 main group and late transition metals.
    Lemon CM; Brothers PJ; Boitrel B
    Dalton Trans; 2011 Jul; 40(25):6591-609. PubMed ID: 21384031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, spectroscopic, molecular orbital calculation, cytotoxic, molecular docking of DNA binding and DNA cleavage studies of transition metal complexes with N-benzylidene-N'-salicylidene-1,1-diaminopropane.
    Al-Mogren MM; Alaghaz AN; Ebrahem EA
    Spectrochim Acta A Mol Biomol Spectrosc; 2013 Oct; 114():695-707. PubMed ID: 23831943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in ruthenium and platinum based supramolecular coordination complexes for antitumor therapy.
    Zhang X; Liu D; Lv F; Yu B; Shen Y; Cong H
    Colloids Surf B Biointerfaces; 2019 Oct; 182():110373. PubMed ID: 31376689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transition metal compounds as cancer radiosensitizers.
    Gill MR; Vallis KA
    Chem Soc Rev; 2019 Jan; 48(2):540-557. PubMed ID: 30499573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and characterization of the ligand based on benzoxazole and its transition metal complexes: DNA-binding and antitumor activity.
    Jiang J; Tang X; Dou W; Zhang H; Liu W; Wang C; Zheng J
    J Inorg Biochem; 2010 May; 104(5):583-91. PubMed ID: 20202687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Application of d6 transition metal complexes in fluorescence cell imaging.
    Fernández-Moreira V; Thorp-Greenwood FL; Coogan MP
    Chem Commun (Camb); 2010 Jan; 46(2):186-202. PubMed ID: 20024327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.